Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity
- 1 June 2000
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 127 (1) , 1-11
- https://doi.org/10.1016/s0009-2797(00)00159-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxaneCancer Chemotherapy and Pharmacology, 1999
- Age-related Acute Adriamycin Cardiotoxicity in MiceJournal of Molecular and Cellular Cardiology, 1994
- A new insight into adriamycin-induced cardiotoxicityInternational Journal of Cardiology, 1990
- Doxorubicin toxicity and pharmacokinetics in old and young ratsExperimental Gerontology, 1989
- Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in ratsCanadian Journal of Physiology and Pharmacology, 1987
- Subcellular effects of adriamycin in the heart: A concise reviewJournal of Molecular and Cellular Cardiology, 1987
- Stimulation by adriamycin of rat heart and liver microsomal NADPH-dependent lipid peroxidationBiochemical Pharmacology, 1981
- Adriamycin cardiotoxicity: Possible pathogenic mechanismsJournal of Molecular and Cellular Cardiology, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977